Angiotensin-converting enzyme gene polymorphism in arrhythmogenic right ventricular dysplasia: Is DD genotype helpful in predicting syncope risk?

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System

Volumn 9, Issue 4, 2008, Pages 215-220

  Ozben, Beste ^a,c   Altun, Ibrahim ^b   Sabri Hancer, Veysel ^b   Bilge, Ahmet Kaya ^b   Tanrikulu, Azra Meryem ^a   Diz Kucukkaya, Reyhan ^b   Fak, Ali Serdar ^a   Yilmaz, Ercument ^b   Adalet, Kamil ^b  

^a MARMARA UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

^c NONE   (Turkey)

Author keywords

Angiotensin converting enzyme gene polymorphism; Arrhythmogenic right ventricular dysplasia; Sudden cardiac death; Syncope; Ventricular tachycardia

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; FAMILY HISTORY; FEMALE; GENE FREQUENCY; GENOTYPE; HEART DEATH; HEART RIGHT VENTRICLE DYSPLASIA; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE TACHYCARDIA; HUMAN; MALE; POLYMERASE CHAIN REACTION; PREVALENCE; RESUSCITATION; RISK ASSESSMENT; SYNCOPE; ALLELE; ENZYMOLOGY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS;

ADULT; ALLELES; ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; SYNCOPE;

EID: 66149092356     PISSN: 14703203     EISSN: None     Source Type: Journal    
DOI: 10.1177/1470320308099126     Document Type: Article

References (48)

1. Fontaine GH, Guiraudon G., Frank R. et al. Stimulation studies and epicardial mapping in ventricular tachycardia: Study of mechanisms and selection for surgery. In: Kulbertus HE (ed.). Reentrant Arrhythmias: Mechanisms and Treatment. Lancaster: MTP Publishing, 1977;334-50.
2. Marcus FI, Fontaine GH, Guiraudon G. et al. Right ventricular dysplasia: a report of 24 adult cases. Circulation 1982;65:384-98.
3. Marcus FI, Fontaine G. Arrhythmogenic right ventricular dysplasia/ cardiomyopathy: A review. Pacing Clin Electrophysiol 1995;18:1298-314.
4. Nava A., Thiene G., Canciani B. et al. Familial occurrence of right ventricular dysplasia: A study involving nine families. J Am Coll Cardiol 1988;12:1222-8.
5. Thiene G., Nava A., Corrado D., Rossi L., Pennelli N. Right ventricular cardiomyopathy and sudden death in young people. N Engl J Med 1988;318:129-33.
6. Basso C., Thiene G., Corrado D., Angelini A., Nava A., Valente M. Arrhythmogenic right ventricular cardiomyopathy. Dysplasia, dystrophy or myocarditis? Circulation 1996;94:983-91.
7. Ananthasubramaniam K., Khaja F. Arrhythmogenic right ventricular dysplasia/cardiomyopathy: Review for the clinician. Prog Cardiovasc Dis 1998;41:237-46.
8. Corrado D., Basso C., Schiavon M., Thiene G. Screening for hypertrophic cardiomyopathy in young athletes. N Engl J Med 1998;339:364-9.
9. Tabib A., Loire R., Chalabreysse L. et al. Circumstances of death and gross and microscopic observations in a series of 200 cases of sudden death associated with arrhythmogenic right ventricular cardiomyopathy and/or dysplasia. Circulation 2003;108:3000-05.
10. Corrado D., Basso C., Thiene G. et al. Spectrum of clinicopathologic manifestations of arrhythmogenic right ventricular cardiomyopathy/ dysplasia: A multicenter study. J Am Coll Cardiol 1997;30:1512-20.
11. Ahmad F. The molecular genetics of arrhythmogenic right ventricular dysplasia-cardiomyopathy. Clin Invest Med 2003;26:167-78.
12. Hamid MS, Norman M., Quraishi A. et al. Prospective evaluation of relatives for familial arrhythmogenic right ventricular cardiomyopathy/ dysplasia reveals a need to broaden diagnostic criteria. J Am Coll Cardiol 2002;40:1445-50.
13. Hermida JS, Minassian A., Jarry G. et al. Familial incidence of late ventricular potentials and electrocardiographic abnormalities in arrhythmogenic right ventricular dysplasia. Am J Cardiol 1997;79:1375-80.
14. Włodarska EK, Konka M., Kepski R. et al. Familial form of arrhythmogenic right ventricular cardiomyopathy. Kardiol Pol 2004;60:1-14.
15. Rampazzo A., Nava A., Malacrida S. et al. Mutation in human desmoplakin domain binding to plakoglobin causes a dominant form of arrhythmogenic right ventricular cardiomyopathy. Am J Hum Genet 2002;71:1200-06.
16. Rampazzo A., Nava A., Danieli GA et al. The gene for arrhythmogenic right ventricular cardiomyopathy maps to chromosome 14q23-14q24. Hum Mol Genet 1994;3:959-62.
17. Matolweni LO, Bardien S., Rebello G. et al. Arrhythmogenic right ventricular cardiomyopathy type 6 (ARVC6): Support for the locus assignment, narrowing of the critical region and mutation screening of three candidate genes. BMC Med Genet 2006; 7: 29.
18. McKoy G., Protonotarios N., Crosby A. et al. Identification of a deletion in plakoglobin in arrhythmogenic right ventricular cardiomyopathy with palmoplantar keratoderma and woolly hair (Naxos disease). Lancet 2000;355:2119-24.
19. Bowles NE, Ni J., Marcus F., Towbin JA The detection of cardiotropic viruses in the myocardium of patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. J Am Coll Cardiol 2002;39:892-5.
20. Cambien F., Alhenc-Gelas F., Herbeth B. et al. Familial resemblance of plasma angiotensin-converting enzyme level: The Nancy Study. Am J Hum Genet 1988;43:774-80.
21. Rigat B., Hubert C., Alhenc-Gelas F., Cambien F., Corvol P., Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990;86:1343-6.
22. Villard E., Soubrier F. Molecular biology and genetics of the angiotensin-I-converting enzyme: Potential implications in cardiovascular diseases. Cardiovasc Res 1996;32:999-1007.
23. Arnett DK, Davis BR, Ford CE et al. Pharmacogenetic association of the angiotensin-converting enzyme insertion/deletion polymorphism on blood pressure and cardiovascular risk in relation to antihypertensive treatment: The Genetics of Hypertension-Associated Treatment (GenHAT) study. Circulation 2005;111:3374-83.
24. Danser AH, Schalekamp MA, Bax WA et al. Angiotensin-converting enzyme in the human heart. Effect of the deletion/insertion polymorphism. Circulation 1995;92:1387-8.
25. Ocaranza MP, Díaz-Araya G., Carreño JE et al. Polymorphism in gene coding for ACE determines different development of myocardial fibrosis in rats. Am J Physiol Heart Circ Physiol 2004;286:H498-H506.
26. Takahashi T., Ueno H., Yasumoto K. et al. Angiotensin-converting enzyme-gene polymorphism is associated with collagen I synthesis and QT dispersion in essential hypertension. J Hypertens 2003;21:985-91.
27. Anvari A., Türel Z., Schmidt A. et al. Angiotensin-converting enzyme and angiotensin II receptor 1 polymorphism in coronary disease and malignant ventricular arrhythmias. Cardiovasc Res 1999;43:879-83.
28. McKenna WJ, Thiene G., Nava A. et al. Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology. Br Heart J 1994;71:215-18.
29. Tiret L., Rigat B., Visvikis S. et al. Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet 1992;51:197-205.
30. Zee RY, Lou YK, Griffiths LR, Morris BJ Association of a polymorphism of the angiotensin I-converting enzyme gene with essential hypertension. Biochem Biophys Res Commun 1992;184:9-15.
31. Rigat B., Hubert C., Corvol P., Soubrier F. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). Nucleic Acids Res 1992;20:1433.
32. Shanmugam V., Sell KW, Saha BK Mistyping ACE heterozygotes. PCR Methods Appl 1993;3:120-1.
33. Lindpaintner K., Pfeffer MA, Kreutz R. et al. A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med 1995;332:706-11.
34. Tiso N., Stephan DA, Nava A. et al. Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2). Hum Mol Genet 2001;10:189-94.
35. Beffagna G., Occhi G., Nava A. et al. Regulatory mutations in transforming growth factor-beta3 gene cause arrhythmogenic right ventricular cardiomyopathy type 1. Cardiovasc Res 2005;65:366-73.
36. Alcalai R., Metzger S., Rosenheck S., Meiner V., Chajek-Shaul T. A recessive mutation in desmoplakin causes arrhythmogenic right ventricular dysplasia, skin disorder, and woolly hair. J Am Coll Cardiol 2003;42:319-27.
37. Gerull B., Heuser A., Wichter T. et al. Mutations in the desmosomal protein plakophilin-2 are common in arrhythmogenic right ventricular cardiomyopathy. Nat Genet 2004;36:1162-4.
38. Guiraudon CM Histological diagnosis of right ventricular dysplasia: A role for electron microscopy? Eur Heart J 1989;10(suppl D):95-6.
39. Roncali L., Nico B., Locuratolo N., Bertossi M., Chiddo A. Right ventricular dysplasia: An ultrastructural study. Eur Heart J 1989;10(suppl D):97-9.
40. Frost D., Pfohl M., Clemens P., Häring HU, Beischer W. Evaluation of the insertion/deletion ACE gene polymorphism as a risk factor for carotid artery intima-media thickening and hypertension in young type 1 diabetic patients. Diabetes Care 1998;21:836-40.
41. Hung J., McQuillan BM, Nidorf M., Thompson PL, Beilby JP Angiotensin-converting enzyme gene polymorphism and carotid wall thickening in a community population. Arterioscler Thromb Vasc Biol 1999;19:1969-74.
42. Ueda S., Elliott HL, Morton JJ, Connell JM Enhanced pressor response to angiotensin I in normotensive men with the deletion genotype (DD) for angiotensin-converting enzyme. Hypertension 1995;25:1266-9.
43. Deshmukh PM, Krishnamani R., Romanyshyn M., Johnson AK, Noti JD Association of angiotensin converting enzyme gene polymorphism with tachycardia cardiomyopathy. Int J Mol Med 2004;13:455-8.
44. Takezako T., Zhang B., Serikawa T., Fan P., Nomoto J., Saku K. The D allele of the angiotensin-converting enzyme gene and reperfusion-induced ventricular arrhythmias in patients with acute myocardial infarction. Jpn Circ J 2001;65:603-09.
45. Kaibara M., Mitarai S., Yano K., Kameyama M. Involvement of Na(+)-H+ antiporter in regulation of L-type Ca2+ channel current by angiotensin II in rabbit ventricular myocytes. Circ Res 1994;75:1121-5.
46. Turrini P., Corrado D., Basso C., Nava A., Thiene G. Noninvasive risk stratification in arrhythmogenic right ventricular cardiomyopathy. Ann Noninvasive Electrocardiol 2003;8:161-9.
47. Zipes DP, Camm AJ, Borggrefe M. et al. American College of Cardiology/ American Heart Association Task Force; European Society of Cardiology Committee for Practice Guidelines; European Heart Rhythm Association and the Heart Rhythm Society. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death - executive summary: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Eur Heart J 2006;27:2099-140.
48. Verma A., Kilicaslan F., Schweikert RA et al. Short- and long-term success of substrate-based mapping and ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia. Circulation 2005;111:3209-16.